However, a solid and broad study focusing on the effects of radiotherapy and chemotherapy on the PD-L1 status of laryngeal cancer is lacking, and it would be important to gain more insights about its possible implications for the outcomes of patients with advanced SCC undergoing immunotherapy in association with conventional therapies. This evidence concerns the gene CD274 and laryngeal carcinoma.